Metabolic network modeling approaches for investigating the "hungry cancer"

Seminars in Cancer Biology

Volumn 23, Issue 4, 2013, Pages 227-234

  Sharma, Ashwini Kumar ^a   König, Rainer ^a,b,c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

^c HANS KNÖLL INSTITUTE   (Germany)

Author keywords

Cancer; Flux balance analysis; Metabolic flux analysis; Metabolism; Networks; Pattern analysis; Regulation

Indexed keywords

CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; CELL METABOLISM; CITRIC ACID CYCLE; COMPUTER MODEL; COMPUTER PROGRAM; CONSTRAINT BASED MODELING; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETIC DATABASE; GLIOBLASTOMA; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MATHEMATICAL MODEL; METABOLIC REGULATION; METABOLOMICS; NONHUMAN; ONLINE SYSTEM; PROTEIN DEGRADATION; REVIEW;

EID: 84881098445     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2013.05.001     Document Type: Review

References (75)

1. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
2. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
3. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314.
4. Resendis-Antonio O., Checa A., Encarnación S. Modeling core metabolism in cancer cells: surveying the topology underlying the Warburg effect. PLoS ONE 2010, 5:1-11.
5. Shlomi T., Benyamini T., Gottlieb E., Sharan R., Ruppin E. Genome-scale metabolic modeling elucidates the role of proliferative adaptation in causing the Warburg effect. PLoS Computational Biology 2011, 7:1-8.
6. Vazquez A., Liu J., Zhou Y., Oltvai Z.N. Catabolic efficiency of aerobic glycolysis: the Warburg effect revisited. BMC Systems Biology 2010, 4:1-9.
7. DeBerardinis R.J., Sayed N., Ditsworth D., Thompson C.B. Brick by brick: metabolism and tumor cell growth. Current Opinion in Genetics and Development 2008, 18:54-61.
8. DeBerardinis R.J., Mancuso A., Daikhin E., Nissim I., Yudkoff M., Wehrli S., et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:19345-19350.
9. Wise D.R., DeBerardinis R.J., Mancuso A., Sayed N., Zhang X.Y., Pfeiffer H.K., et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:18782-18787.
10. Schramm G., Wiesberg S., Diessl N., Kranz A.L., Sagulenko V., Oswald M., et al. PathWave: discovering patterns of differentially regulated enzymes in metabolic pathways. Bioinformatics 2010, 26:1225-1231.
11. Tönjes M., Barbus S., Park Y.J., Wang W., Schlotter M., Lindroth A.M., et al. BCAT1 promotes cell proliferation via amino acid catabolism in IDH1 wildtype gliomas. Nature Medicine 2013, (in press).
12. Samudio I., Harmancey R., Fiegl M., Kantarjian H., Konopleva M., Korchin B., et al. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. Journal of Clinical Investigation 2010, 120:142-156.
13. Schramm G., Surmann E.M., Wiesberg S., Oswald M., Reinelt G., Eils R., et al. Analyzing the regulation of metabolic pathways in human breast cancer. BMC Medical Genomics 2010, 3:1-10.
14. Eichner L.J., Perry M.C., Dufour C.R., Bertos N., Park M., St-Pierre J., et al. miR-378* mediates metabolic shift in breast cancer cells via the PGC-1beta/ERRgamma transcriptional pathway. Cell Metabolism 2010, 12:352-361.
15. Bensaad K., Tsuruta A., Selak M.A., Vidal M.N., Nakano K., Bartrons R., et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006, 126:107-120.
16. Matoba S., Kang J.G., Patino W.D., Wragg A., Boehm M., Gavrilova O., et al. p53 regulates mitochondrial respiration. Science 2006, 312:1650-1653.
17. Dang C.V., Semenza G.L. Oncogenic alterations of metabolism. Trends in Biochemical Sciences 1999, 24:68-72.
18. Zhou M., Zhao Y., Ding Y., Liu H., Liu Z., Fodstad O., et al. Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol. Molecular Cancer 2010, 9:1-12.
19. Kanfi Y., Naiman S., Amir G., Peshti V., Zinman G., Nahum L., et al. The sirtuin SIRT6 regulates lifespan in male mice. Nature 2012, 483:218-221.
20. Sebastián C., Zwaans B.M., Silberman D.M., Gymrek M., Goren A., Zhong L., et al. The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell 2012, 151:1185-1199.
21. Plaimas K., Eils R., König R. Identifying essential genes in bacterial metabolic networks with machine learning methods. BMC Systems Biology 2010, 4:1-16.
22. Pey J., Prada J., Beasley J.E., Planes F.J. Path finding methods accounting for stoichiometry in metabolic networks. Genome Biology 2011, 12:1-14.
23. Schmidt-Gienewinkel H., Legewie S., Brors B., König R. Cellular systems biology. An introduction to molecular biotechnology 2011, 295-309. Wiley Blackwell, Weinheim. M. Wink (Ed.).
24. Schellenberger J., Park J.O., Conrad T.M., Palsson B.Ø. BiGG: a biochemical genetic and genomic knowledgebase of large scale metabolic reconstructions. BMC Bioinformatics 2010, 11:1-10.
25. Romero P., Wagg J., Green M.L., Kaiser D., Krummenacker M., Karp P.D. Computational prediction of human metabolic pathways from the complete human genome. Genome Biology 2005, 6:R2.1-R2.17.
26. Kanehisa M., Goto S. KEGG: Kyoto Encyclopedia of genes and genomes. Nucleic Acids Research 2000, 28:27-30.
27. Fisher R.A. On the interpretation of ?2 from contingency tables, and the calculation of P. Journal of the Royal Statistical Society 1922, 85:87-94.
28. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:15545-15550.
29. Patil K.R., Nielsen J. Uncovering transcriptional regulation of metabolism by using metabolic network topology. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:2685-2689.
30. Chang T., Kuo C.-C. Texture analysis and classification with tree-structured wavelet transform. IEEE Transactions on Image Processing 1993, 2:429-441.
31. Mallat S. A wavelet tour of signal processing 1998, Academic Press, New York.
32. Jeong H., Tombor B., Albert R., Oltvai Z.N., Barabasi A.L. The large-scale organization of metabolic networks. Nature 2000, 407:651-654.
33. Lewis N.E., Schramm G., Bordbar A., Schellenberger J., Andersen M.P., Cheng J.K., et al. Large-scale in silico modeling of metabolic interactions between cell types in the human brain. Nature Biotechnology 2010, 28:1279-1285.
34. Orth J.D., Thiele I., Palsson B.Ø. What is flux balance analysis?. Nature Biotechnology 2010, 28:245-248.
35. Thiele I., Palsson B.Ø. A protocol for generating a high-quality genome-scale metabolic reconstruction. Nature Protocols 2010, 5:93-121.
36. Li C., Donizelli M., Rodriguez N., Dharuri H., Endler L., Chelliah V., et al. BioModels database: an enhanced, curated and annotated resource for published quantitative kinetic models. BMC Systems Biology 2010, 4:1-14.
37. Overbeek R., Begley T., Butler R.M., Choudhuri J.V., Chuang H.Y., Cohoon M., et al. The subsystems approach to genome annotation and its use in the project to annotate 1000 genomes. Nucleic Acids Research 2005, 33:5691-5702.
38. Thiele I., Swainston N., Fleming R.M., Hoppe A., Sahoo S., Aurich M.K., et al. A community-driven global reconstruction of human metabolism. Nature Biotechnology 2013, 31:419-425.
39. Jerby L., Shlomi T., Ruppin E. Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism. Molecular Systems Biology 2010, 6:1-9.
40. Becker S.A., Palsson B.O. Context-specific metabolic networks are consistent with experiments. PLoS Computational Biology 2008, 4:1-10.
41. Agren R., Bordel S., Mardinoglu A., Pornputtapong N., Nookaew I., Nielsen J. Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INIT. PLoS Computational Biology 2012, 8:1-9.
42. Wang Y., Eddy J.A., Price N.D. Reconstruction of genome-scale metabolic models for 126 human tissues using mCADRE. BMC Systems Biology 2012, 6:1-16.
43. Schellenberger J., Que R., Fleming R.M., Thiele I., Orth J.D., Feist A.M., et al. Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2. 0. Nature Protocols 2011, 6:1290-1307.
44. Hoops S., Sahle S., Gauges R., Lee C., Pahle J., Simus N., et al. COPASI - a COmplex PAthway SImulator. Bioinformatics 2006, 22:3067-3074.
45. Klamt S., Saez-Rodriguez J., Gilles E.D. Structural and functional analysis of cellular networks with CellNetAnalyzer. BMC Systems Biology 2007, 1:1-13.
46. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols 2009, 4:44-57.
47. Wiechert W., Möllney M., Petersen S., de Graaf A.A. A universal framework for 13C metabolic flux analysis. Metabolic Engineering 2001, 3:265-283.
48. Zamboni N., Fischer E., Sauer U. FiatFlux - a software for metabolic flux analysis from 13C-glucose experiments. BMC Bioinformatics 2005, 6:1-8.
49. Jensen P.A., Lutz K.A., Papin J.A. TIGER: toolbox for integrating genome-scale metabolic models, expression data, and transcriptional regulatory networks. BMC Systems Biology 2011, 5:1-12.
50. Funahashi A., Tanimura N., Morohashi M., Kitano H. CellDesigner: a process diagram editor for gene-regulatory and biochemical networks. BIOSILICO 2003, 1:159-162.
51. Droste P., Miebach S., Niedenführ S., Wiechert W., Nöh K. Visualizing multi-omics data in metabolic networks with the software Omix - a case study. Biosystems 2011, 105:154-161.
52. Bourqui R., Cottret L., Lacroix V., Auber D., Mary P., Sagot M.F., et al. Metabolic network visualization eliminating node redundance and preserving metabolic pathways. BMC Systems Biology 2007, 1:1-19.
53. Villéger A.C., Pettifer S.R., Kell D.B. Arcadia: a visualization tool for metabolic pathways. Bioinformatics 2010, 26:1470-1471.
54. Mahadevan R., Schilling C.H. The effects of alternate optimal solutions in constraint-based genome-scale metabolic models. Metabolic Engineering 2003, 5:264-276.
55. Papin J.A., Stelling J., Price N.D., Klamt S., Schuster S., Palsson B.Ø. Comparison of network-based pathway analysis methods. Trends in Biotechnology 2004, 22:400-405.
56. Schellenberger J., Palsson B.Ø. Use of randomized sampling for analysis of metabolic networks. Journal of Biological Chemistry 2009, 284:5457-5461.
57. Frezza C., Zheng L., Folger O., Rajagopalan K.N., MacKenzie E.D., Jerby L., et al. Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature 2011, 477:225-228.
58. Folger O., Jerby L., Frezza C., Gottlieb E., Ruppin E., Shlomi T. Predicting selective drug targets in cancer through metabolic networks. Molecular Systems Biology 2011, 7:501.
59. Li L., Zhou X., Ching W.K., Wang P. Predicting enzyme targets for cancer drugs by profiling human metabolic reactions in NCI-60 cell lines. BMC Bioinformatics 2010, 11:501.
60. Wiechert W. 13C metabolic flux analysis. Metabolic Engineering 2001, 3:195-206.
61. Zamboni N. 13C metabolic flux analysis in complex systems. Current Opinion in Biotechnology 2011, 22:103-108.
62. Zamboni N., Fendt S.M., Rühl M., Sauer U. 13C-based metabolic flux analysis. Nature Protocols 2009, 4:878-892.
63. Metallo C.M., Walther J.L., Stephanopoulos G. Evaluation of 13C isotopic tracers for metabolic flux analysis in mammalian cells. Journal of Biotechnology 2009, 144:167-174.
64. Leighty R.W., Antoniewicz M.R. Dynamic metabolic flux analysis (DMFA): a framework for determining fluxes at metabolic non-steady state. Metabolic Engineering 2011, 13:745-755.
65. Chagoyen M., Pazos F. MBRole: enrichment analysis of metabolomic data. Bioinformatics 2011, 27:730-731.
66. Xia J., Mandal R., Sinelnikov I.V., Broadhurst D., Wishart D.S. MetaboAnalyst 2.0 - a comprehensive server for metabolomic data analysis. Nucleic Acids Research 2012, 40(Web Server issue):W127-W133.
67. Tautenhahn R., Cho K., Uritboonthai W., Zhu Z., Patti G.J., Siuzdak G. An accelerated workflow for untargeted metabolomics using the METLIN database. Nature Biotechnology 2012, 30:826-828.
68. Horai H., Arita M., Kanaya S., Nihei Y., Ikeda T., Suwa K., et al. MassBank: a public repository for sharing mass spectral data for life sciences. Journal of Mass Spectrometry 2010, 45:703-714.
69. Wishart D.S., Jewison T., Guo A.C., Wilson M., Knox C., Liu Y., et al. HMDB 3.0 - the human metabolome database in 2013. Nucleic Acids Research 2013, 41(Database issue):D801-D807.
70. Benjamin D.I., Cravatt B.F., Nomura D.K. Global profiling strategies for mapping dysregulated metabolic pathways in cancer. Cell Metabolism 2012, 16:565-577.
71. Kloosterhof N.K., Bralten L.B., Dubbink H.J., French P.J., van den Bent M.J. Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?. Lancet Oncology 2011, 12:83-91.
72. Mullen A.R., Wheaton W.W., Jin E.S., Chen P.H., Sullivan L.B., Cheng T., et al. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 2011, 481:385-388.
73. Locasale J.W., Grassian A.R., Melman T., Lyssiotis C.A., Mattaini K.R., Bass A.J., et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nature Genetics 2011, 43:869-874.
74. Possemato R., Marks K.M., Shaul Y.D., Pacold M.E., Kim D., Birsoy K., et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 2011, 476:346-350.
75. Cheng T., Sudderth J., Yang C., Mullen A.R., Jin E.S., Matés J.M., et al. Pyruvate carboxylase is required for glutamine-independent growth of tumor cells. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:8674-8679.